Progesterone receptor promotes degradation of STAT2 to inhibit the interferon response in breast cancer.
Ontology highlight
ABSTRACT: Type I (IFNα/β) interferon signaling represents a critical transduction pathway involved in recognition and destruction of nascent tumor cells. Downregulation of this pathway to promote a more immunosuppressed microenvironment contributes to the ability of tumor cells to evade the immune system, a known Hallmark of Cancer. The present study investigates the progesterone receptor (PR), which is expressed in the vast majority of breast cancers, and its ability to inhibit efficient interferon signaling in tumor cells. We have shown that PR can block the interferon signaling cascade by promoting ubiquitination and degradation of STAT2. Targeting STAT2 is critical, as we show that it is an essential protein in inducing transcription of interferon-stimulated genes (ISG); shRNA-mediated knockdown
SUBMITTER: Walter KR
PROVIDER: S-EPMC7199813 | biostudies-literature | 2020
REPOSITORIES: biostudies-literature
ACCESS DATA